Institute for Clinical Evaluative Sciences
Toronto, Ontario, M4N 3M5, Canada
NCT Number: NCT01411865
Diabetes is a common and serious chronic disease. However, there is a large gap between the level of care that people should receive (based on research and guidelines) and the level of care they actually receive. With the release of their 2008 Clinical Practice Guidelines, the Canadian Diabetes Association has a strategy to improve heart disease screening and treatment for people with diabetes. This study will evaluate whether the strategy works. The focus of the strategy was to give all family physicians in Canada a Toolkit in June 2009 to help them delivery better care for their diabetic patients. In Ontario, only half of doctors received this Toolkit. We will compare the quality of care received by diabetic patients whose doctors received this Toolkit versus those who doctors did not.
Looking for future studies?
Notify Me40 year and older
All sexes
Interventional
Not applicable
Toronto, Ontario, M4N 3M5, Canada
A cardiovascular disease Toolkit was developed by the Canadian Diabetes Association and mailed to family physician with the Spring/Summer 2009 edition of the newsletter, Canadian Diabetes. The Toolkit was packaged in a brightly-coloured box with Canadian Diabetes Association branding, and contained: 1) an introductory letter from the Chair of the practice guidelines' Dissemination and Implementation Committee; 2) an eight page summary of selected sections of the practice guidelines targeted towards primary care physicians; 3) a four page synopsis of the key guideline elements pertaining to cardiovascular disease risk; 4) a small double-sided laminated card with a simplified algorithm for cardiovascular risk assessment, vascular protection strategies and screening for cardiovascular disease; and 5) a pad of tear-off sheets for patients with a cardiovascular risk self-assessment tool and a list of recommended risk reduction strategies.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Secondary Analysis:
Cardiovascular Disease Toolkit mailed by the Canadian Diabetes Association to family physicians, accompanying the Spring/Summer 2009 edition of the quarterly newsletter, Canadian Diabetes. (Mailed in June 2009.) The Toolkit includes a summary of selected sections of the practice guidelines targeted towards primary care physicians; a synopsis of the key messages pertaining to cardiovascular disease risk; a laminated card with a simplified algorithm for cardiovascular risk assessment and treatment; and a pad of tear-off sheets for patients with a cardiovascular risk self-assessment tool.
The Spring/Summer 2009 issue of the quarterly newsletter, Canadian Diabetes, mailed on its own. The Cardiovascular Toolkit was mailed with the May 2010 issue of the newsletter.
Time frame: Up to 10 months
Time frame: Up to 10 months
Time frame: Up to 10 months
Time frame: Up to 10 months
Time frame: Up to 10 months
Time frame: Up to 10 months
Time frame: Up to 10 months
Time frame: Up to 10 months
Time frame: Up to 10 months
Time frame: Up to 10 months
Time frame: Up to 10 months
Time frame: Up to 10 months
Time frame: Up to 10 months
Time frame: Up to 10 months
Time frame: Up to 10 months
Time frame: Up to 10 months
Time frame: Up to 10 months
Time frame: Up to 10 months
Time frame: Up to 10 months
Time frame: Up to 10 months
Time frame: Up to 10 months
Sunnybrook Health Sciences Centre
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01934660
Cardiovascular Disease, Cardiovascular Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT04977583
Cardiovascular Disease, Cardiovascular Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT02787785
Arrhythmias, Cardiac, Cardiac Conduction System Disease
Huntsville, Alabama, United States
View Trial DetailsNCT02325531
Cardiovascular Disease, Cardiovascular Diseases
Portland, Oregon, United States
View Trial Details